2010 Press releases

Displaying 1 - 10 of 29

20 December 2010
Clavis Pharma’s elacytarabine granted FDA Fast Track designation in USA

Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, announces that its clinical development programme with elacytarabine for the treatment of patients with acute myeloid leukaemia (AML) ...

10 December 2010
Prospectus approved

9 December 2010
Clavis Pharma’s NOK 154 million Private Placement approved at Extraordinary General Meeting

Clavis Pharma ASA (OSE: CLAVIS) announces that all items proposed to shareholders at its extraordinary general meeting held today in Oslo were resolved according the Board's proposal...

18 November 2010
Clavis Pharma raises NOK 154 million (EUR 19 million) in a private placement

Clavis Pharma ASA (OSE: CLAVIS) (the "Company") today announces that the Company has raised NOK 154 million ..

11 November 2010
Clavis Pharma and Clovis Oncology Extend Partnership and Sign New $205 Million Deal for the Development and Commercialisation of Anti-Cancer Agent CP-4126 in Asia and Rest of the World

Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug discovery and development company, and Clovis Oncology, Inc., announced today a new agreement ...